1. Fredholm, B. B., IJzerman, A. P., Jacobson, K. A., Linden, J. & Müller, C. E. International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors—an update. Pharmacol. Rev. 63, 1–34 (2011).

2. Jacobson, K. A. & Gao, Z.-G. Adenosine receptors as therapeutic targets. Nat. Rev. Drug Discov. 5, 247–264 (2006).

3. Nguyen, A. T. N. et al. Role of the second extracellular loop of the adenosine A 1 receptor on allosteric modulator binding, signaling, and cooperativity. Mol. Pharmacol. 90, 715–725 (2016).

4. Valant, C. et al. Separation of on-target efficacy from adverse effects through rational design of a bitopic adenosine receptor agonist. Proc. Natl Acad. Sci. USA 111, 4614–4619 (2014).

5. Cheng, R. K. Y. et al. Structures of human A 1 and A 2A adenosine receptors with xanthines reveal determinants of selectivity. Structure 25, 1275–1285.e4 (2017).

6. Glukhova, A. et al. Structure of the adenosine A 1 receptor reveals the basis for subtype selectivity. Cell 168, 867–877.e13 (2017).

7. Liang, Y.-L. et al. Phase-plate cryo-EM structure of a class B GPCR–G-protein complex. Nature 546, 118–123 (2017).

8. Liang, Y.-L. et al. Phase-plate cryo-EM structure of a biased agonist-bound human GLP-1 receptor–G s complex. Nature 555, 121–125 (2018).

9. Zhang, Y. et al. Cryo-EM structure of the activated GLP-1 receptor in complex with a G protein. Nature 546, 248–253 (2017).

10. Rasmussen, S. G. F. et al. Crystal structure of the β 2 adrenergic receptor–Gs protein complex. Nature 477, 549–555 (2011).

11. Alexander, S. P. et al. The Concise Guide To Pharmacology 2017/18: G protein-coupled receptors. Br. J. Pharmacol. 174 (Suppl. 1), S17–S129 (2017).

12. De Lean, A., Stadel, J. M. & Lefkowitz, R. J. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. J. Biol. Chem. 255, 7108–7117 (1980).

13. Carpenter, B., Nehmé, R., Warne, T., Leslie, A. G. W. & Tate, C. G. Structure of the adenosine A 2A receptor bound to an engineered G protein. Nature 536, 104–107 (2016).

14. Huang, W. et al. Structural insights into µ-opioid receptor activation. Nature 524, 315–321 (2015).

15. Kruse, A. C. et al. Activation and allosteric modulation of a muscarinic acetylcholine receptor. Nature 504, 101–106 (2013).

16. Rasmussen, S. G. F. et al. Structure of a nanobody-stabilized active state of the β 2 adrenoceptor. Nature 469, 175–180 (2011).

17. Che, T. et al. Structure of the nanobody-stabilized active state of the kappa opioid receptor. Cell 172, 55–67.e15 (2018).

18. Erlandson, S. C., McMahon, C. & Kruse, A. C. Structural basis for G protein-coupled receptor signaling. Annu. Rev. Biophys. 47, 1–18 (2018).

19. Rosenbaum, D. M. et al. GPCR engineering yields high-resolution structural insights into β 2 -adrenergic receptor function. Science 318, 1266–1273 (2007).

20. Savinainen, J. R., Saario, S. M., Niemi, R., Järvinen, T. & Laitinen, J. T. An optimized approach to study endocannabinoid signaling: evidence against constitutive activity of rat brain adenosine A 1 and cannabinoid CB 1 receptors. Br. J. Pharmacol. 140, 1451–1459 (2003).

21. Liu, W. et al. Structural basis for allosteric regulation of GPCRs by sodium ions. Science 337, 232–236 (2012).

22. Rasmussen, S. G. F. et al. Crystal structure of the human β 2 adrenergic G-protein-coupled receptor. Nature 450, 383–387 (2007).

23. Haga, K. et al. Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist. Nature 482, 547–551 (2012).

24. Manglik, A. et al. Crystal structure of the µ-opioid receptor bound to a morphinan antagonist. Nature 485, 321–326 (2012).

25. Rivkees, S. A., Barbhaiya, H. & IJzerman, A. P. Identification of the adenine binding site of the human A 1 adenosine receptor. J. Biol. Chem. 274, 3617–3621 (1999).

26. Townsend-Nicholson, A. & Schofield, P. R. A threonine residue in the seventh transmembrane domain of the human A 1 adenosine receptor mediates specific agonist binding. J. Biol. Chem. 269, 2373–2376 (1994)

27. Lebon, G. et al. Agonist-bound adenosine A 2A receptor structures reveal common features of GPCR activation. Nature 474, 521–525 (2011).

28. Nguyen, A. T. N. et al. Extracellular loop 2 of the adenosine A 1 receptor has a key role in orthosteric ligand affinity and agonist efficacy. Mol. Pharmacol. 90, 703–714 (2016).

29. Flock, T. et al. Universal allosteric mechanism for Gα activation by GPCRs. Nature 524, 173–179 (2015).

30. Stewart, G. D. et al. Determination of adenosine A 1 receptor agonist and antagonist pharmacology using Saccharomyces cerevisiae: implications for ligand screening and functional selectivity. J. Pharmacol. Exp. Ther. 331, 277–286 (2009).

31. Oldham, W. M. & Hamm, H. E. Heterotrimeric G protein activation by G-protein-coupled receptors. Nat. Rev. Mol. Cell Biol. 9, 60–71 (2008).

32. Choe, H.-W. et al. Crystal structure of metarhodopsin II. Nature 471, 651–655 (2011).

33. Rose, A. S. et al. Position of transmembrane helix 6 determines receptor G protein coupling specificity. J. Am. Chem. Soc. 136, 11244–11247 (2014).

34. Ballesteros, J. A. & Weinstein, H. Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors. Methods Neurosci 25, 366–428 (1995).

35. Cleator, J. H., Mehta, N. D., Kurtz, D. T. & Hildebrandt, J. D. The N54 mutant of Gα s has a conditional dominant negative phenotype which suppresses hormone-stimulated but not basal cAMP levels. FEBS Lett. 443, 205–208 (1999).

36. Iiri, T., Bell, S. M., Baranski, T. J., Fujita, T. & Bourne, H. R. A G sα mutant designed to inhibit receptor signaling through G s . Proc. Natl Acad. Sci. USA 96, 499–504 (1999).

37. Lee, E., Taussig, R. & Gilman, A. G. The G226A mutant of G sα highlights the requirement for dissociation of G protein subunits. J. Biol. Chem. 267, 1212–1218 (1992).

38. Posner, B. A., Mixon, M. B., Wall, M. A., Sprang, S. R. & Gilman, A. G. The A326S mutant of G iα1 as an approximation of the receptor-bound state. J. Biol. Chem. 273, 21752–21758 (1998).

39. Danev, R., Buijsse, B., Khoshouei, M., Plitzko, J. M. & Baumeister, W. Volta potential phase plate for in-focus phase contrast transmission electron microscopy. Proc. Natl Acad. Sci. USA 111, 15635–15640 (2014).

40. Khoshouei, M., Danev, R., Plitzko, J. M. & Baumeister, W. Revisiting the structure of hemoglobin and myoglobin with cryo-electron microscopy. J. Mol. Biol. 429, 2611–2618 (2017).

41. Khoshouei, M. et al. Volta phase plate cryo-EM of the small protein complex Prx3. Nat. Commun. 7, 10534 (2016).

42. Khoshouei, M., Radjainia, M., Baumeister, W. & Danev, R. Cryo-EM structure of haemoglobin at 3.2 Å determined with the Volta phase plate. Nat. Commun. 8, 16099 (2017).

43. Mastronarde, D. N. Automated electron microscope tomography using robust prediction of specimen movements. J. Struct. Biol. 152, 36–51 (2005).

44. Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331–332 (2017).

45. Zhang, K. Gctf: Real-time CTF determination and correction. J. Struct. Biol. 193, 1–12 (2016).

46. Tang, G. et al. EMAN2: an extensible image processing suite for electron microscopy. J. Struct. Biol. 157, 38–46 (2007).

47. Kimanius, D., Forsberg, B. O., Scheres, S. H. & Lindahl, E. Accelerated cryo-EM structure determination with parallelisation using GPUs in RELION-2. eLife 5, 19 (2016).

48. Arnold, K., Bordoli, L., Kopp, J. & Schwede, T. The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 22, 195–201 (2006).

49. Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D 66, 213–221 (2010).

50. Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D 66, 486–501 (2010).

51. Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D 66, 12–21 (2010).

52. Burnley, T., Palmer, C. M. & Winn, M. Recent developments in the CCP-EM software suite. Acta Crystallogr. D 73, 469–477 (2017).

53. Brown, A. et al. Tools for macromolecular model building and refinement into electron cryo-microscopy reconstructions. Acta Crystallogr. D 71, 136–153 (2015).

54. Afonine, P.V. et al. New tools for the analysis and validation of Cryo-EM maps and atomic models. bioRxiv https://doi.org/10.1101/279844 (2018).